Bacampicillin Hydrochloride

盐酸巴氨西林

Report date: 2026/02/10 20:00:22
NME

Base Information

Drug NameBacampicillin Hydrochloride
Drug Alias NameBacampicillinum巴坎西林盐酸盐bacampicilina氨苄青霉素特戊酰氧甲酯bacampicilline +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsProteus Mirabilis InfectionEnterococcus InfectionsUrinary Tract Infections +[14] 
Global Approved IndicationsProteus Mirabilis InfectionEnterococcus InfectionsUrinary Tract Infections +[14] 
Approved Indications in ChinaUrinary Tract InfectionsSoft Tissue InfectionsRespiratory Tract Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1980/12/22
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesNichi-Iko Pharmaceutical Co LtdHeilongjiang Fuhe Huaxing Pharmaceutical Group Co Ltd
Inactive CompaniesPfizer Inc
Active IndicationsProteus Mirabilis InfectionEnterococcus InfectionsUrinary Tract Infections +[11] 
Inactive IndicationsGonorrheaBacterial InfectionsInfections

Other Information

ATC CodeJ01CA06
Related LinksWikipediaDrugBankKEGG